Weight-loss supplements are rebranding as “GLP-1 boosters.” They’re nothing like Ozempic. If you had come across the ...

Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) given to adolescents with obesity was associated with a one-third ...

A review of the medical records of thousands of adolescents treated for obesity found that kids who received the GLP-1 ...

In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and ...

No signal for an increase in suicidal ideation or attempts associated with GLP-1 use was seen across subgroups stratified by ...

A review of the recent evidence suggests that GLP-1 drugs, such as semaglutide, could protect brain health and cognitive ...

The future of the weight loss market might not revolve around GLP-1 drugs.

Researchers estimate that expanding access to weight-loss drugs could save over 50,000 lives annually, reducing obesity rates ...

This is just a sneak peek at the thousands of consumer insights available to CivicScience clients. Discover more data. The ...

Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have ...

Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have ...

As with any new drug, parents and doctors may worry that the use of GLP-1 weight-loss meds by children and teens might raise ...